Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-603-3 | CAS number: 85-41-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Referenceopen allclose all
- Reference Type:
- publication
- Title:
- Metabolic and toxic behaviours of phthalimide derivatives in albino rat
- Author:
- Ackermann H, Faust H, Kagan YS, and Voronina VH
- Year:
- 1 978
- Bibliographic source:
- Arch Toxicol 40: 255-261
- Reference Type:
- secondary source
- Title:
- Dimethyl phosphonate - CAS No: 868-85-9 - SIDS Initial Assessment Report.
- Author:
- OECD
- Year:
- 2 004
- Bibliographic source:
- UNEP Publications
Materials and methods
- Objective of study:
- other: placental transfer
- Principles of method if other than guideline:
- Radiolabelled phthalimide (250 mg/kg/day) was administered by gavage to pregnant rats between gestational day (GD) 16 and GD18 in order to study the plancental transfer of phthalimide. After 10, 20, 30, 60, 120, 240, and 360 minutes pregnant animals were decapitated and the fetuses were removed.
- GLP compliance:
- no
Test material
- Reference substance name:
- Phthalimide
- EC Number:
- 201-603-3
- EC Name:
- Phthalimide
- Cas Number:
- 85-41-6
- Molecular formula:
- C8H5NO2
- IUPAC Name:
- 1H-isoindole-1,3(2H)-dione
- Details on test material:
- - Name of test material (as cited in study report): phthalimide
- Analytical purity: not reported
Constituent 1
- Radiolabelling:
- yes
- Remarks:
- 15N
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
Administration / exposure
- Route of administration:
- oral: gavage
- Duration and frequency of treatment / exposure:
- Animals were decapited 10, 20, 30, 60, 120, 240, and 360 minutes after exposure
Doses / concentrations
- Remarks:
- Doses / Concentrations:
250 mg/kg bw
- No. of animals per sex per dose / concentration:
- 9-12 animals
- Control animals:
- no
- Details on dosing and sampling:
- EXPERIMENTAL ARRANGEMENT
STUDIES INTO PLACENTAL TRANSFER OF 15N-PHTHALIMIDE
No impurities were recordable by thin-layer chromatography from the recrystallised synthetic products. Suspended in ethoxose solution, they were applied via stomach tube to pregnant Wistar-strain albino rats between the 16th and 18th days p.c. The dose was 25 mg/100g live weight. 10, 20, 30, 60, 120, 240, and 360 min were allowed to elapse, before the pregnant animals were decapitated under hexobarbital anaesthesia and the foetuses removed and weighed.
DEGRADATION OF CHLOROMETHYL PHTHALIMIDE, OXYMETHYL PHTHALIMIDE, AND PHTHALIMIDE IN ISOLATED RAT FOETUSES
Foetuses removed by caesarean section on the 19th or 20th day p.c. were given an intraperitoneal injection of 25µg of the phthalimide derivative per gram of live weight. The animals then were kept in an incubator at 38° in humidity-saturated atmosphere. Between nine and twelve animals each were decapitated after 10, 20, 30, 60, 120, 240, and 360 min and additionally prepared and processed in a way described below.
CHEMICAL TESTS
Three foetuses each were pooled into one sample, and, following preliminary crushing, 8 g were extracted by intensive homogenisation with some 30 mL of chloroform/methanol (80+20). The organic phase was separated by centrifugation, and the residue was subjected twice to the same treatment with about 30 mL chloroform. The combined chloroform phases were washed in 10 mL of distilled water, dried over sodium sulphate following separation of aqueous phase, and evaporated to dryness in a rotation evaporator. The residue was dissolved in 0.5 mL of chloroform/methanol (80+20).
The phthalimide derivatives were detected and determined following separation by thin-layer chromatography (mobile phase benzene/acetone 9+1). The plate, after being relieved from the solvent, was heated to 180°C for 1 hour, before it was treated 10 min in a chlorine atmosphere. Then, application of ethanol spray was followed by colour reaction of the strains, the latter through sprayed application of a mixture of 1% potassium iodide and 2% starch solution, their quantitative ratio being 1:1. Chloromethyl phthalimide, oxymethyl phthalimide, and phthalimide were displayed as bluish-violet spots, detective sensitivity being between 50 ng and 100 mg per spot. Phthalimic acid, a metabolite with opened phthalimide ring, stayed at the point of departure.
DETERMINATION OF 15N-ABUNDANCE
Aliquote parts of chloroform extract mineralised in the presence of sulphuric acid and selenium reaction mixture. Total nitrogen then was determined photometrically by indophenol-blue method, and the ammonia nitrogen was distilled into hydrochloric acid solution by the usual Kjeldahl technique. A certain amount of unlabelled ammonium chloride then was added, before the distillate was evaporated to dryness and the 15N-abundance determined by emission spectrometry.
IN VITRO DEGRADATION OF CHLOROMETHYL PHTALIMIDE
Freshly obtained blood was mixed with the same volume of 1.15% aqueous potassium chloride solution and centrifuged 15 min at 6000 rpm. The supernatant was used for the test proper. When it came to preparations with liver homogenate, 5 g liver were homogenised with 10 mL 1.15% potassium chloride solution and centrifuged 10 min at 4000 rpm, before, again, the supernatant was used for actual investigation.
APPROACH
2.0 mL Ringer solution, 0.5 mL Co-factors (6 mg NAD+ 122 mg nicotinamide/5 mL Ringer solution), 0.5 mL chloronethyl phthalimide solution (1mg/0.5 mL 2% aqueous ethoxose solution), 2 mL substrate (plasma or liver); time of incubation: 15, 30 and 60 min; temperature: 37°C; shaking frequency: 90/min.
DETERMINATION
The flasks were taken off as soon as their incubation periods had run out. They were diluted with 10 mL of distilled water and immediately extracted twice with 10 mL of chloroform. The combined chloroform extracts were washed in 10 mL of distilled water, dried with sodium sulphate, and evaporated to 1 mL. Chloromethyl phthalimide, oxymethyl phathalimde, and phthalimide were determined by thin-layer chromatography in aliquote parts of the extract.
Heat-treated organ homogenates were used for studies into recovery. Chloromethyl phthalimide and its metabolites were quantitatively recovered, the error of TCL determination being ± 20%.
All calculated standard deviations, therefore, are within the normals of biological deviations, that is between ± 25 and ± 35%.
Results and discussion
Toxicokinetic / pharmacokinetic studies
Transfer into organs
- Transfer type:
- blood/placenta barrier
- Observation:
- distinct transfer
Toxicokinetic parameters
- Test no.:
- #1
- Toxicokinetic parameters:
- half-life 1st: between 80 and 90 minutes
Any other information on results incl. tables
Maximum radiolabel concentrations were reached in fetuses within 30 min after application. Strong decline in concentration occurred subsequently and appeared to indicate excessive secretion or continued metabolism, and the detection limit was reached after 2 hours.
Determination of Half Life of Phthalimide in Isolated Rat Foetuses
Phathalimide half life was derived from measurements up to 2 hours and found to have been between 80 and 90 minutes. Longer incubation periods were not taken to the record, since some of the animals had died due to excessive alcohol application, which had amounted to 2.5 µL/g live weight. Phthalimide half life, consequently, was clearly above that of imidan or imidoxone.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
